- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07840885
Illuminated Chopper in Cataract Surgery (IChopper)
Prospective Randomized, Paired-Eye, Comparative Study Between Cataract Surgeries With and Without an Illuminated Chopper
This study compares cataract surgery performed with an illuminated chopper and intracameral illumination with cataract surgery performed under conventional external coaxial microscope illumination. Participants undergoing bilateral cataract surgery will have one eye treated with the illuminated chopper and the other eye treated without the illuminated chopper, with the order randomized between eyes.
The study will evaluate differences in operation time, pupil size, the need for additional intraocular medications or devices, intraoperative and postoperative complications, and postoperative clinical outcomes including visual acuity and intraocular pressure.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This is a prospective, randomized, paired-eye comparative clinical study in participants undergoing bilateral cataract surgery. Each participant will undergo cataract surgery in both eyes. One eye will be treated using the iChopper illumination chopper with the iVision light source, while the fellow eye will undergo cataract surgery using conventional external coaxial microscope illumination. The order of the surgical method between the right and left eyes will be randomized.
The illuminated chopper provides intracameral illumination during cataract surgery and is designed to improve visualization of intraocular structures while also functioning as a lens chopper. The investigational device has received U.S. FDA 510(k) clearance.
The study will assess intraoperative outcomes including operation time, pupil size, ultrasound usage time, pupil-related surgical difficulties, intraoperative complications, and the use of additional intraocular medications or devices. Postoperative assessments will include visual acuity, manifest refraction, intraocular pressure, and postoperative complications.
Participants will undergo bilateral cataract surgery with the two procedures scheduled approximately 1 to 3 weeks apart. Follow-up assessments will be performed approximately 1 day and 30 days after surgery for each eye.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Florida
-
Cape Coral, Florida, Verenigde Staten, 33904
- Tyson Eye
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age 40 years or older
- Diagnosis of bilateral cataract
- Both eyes suitable for cataract surgery
- Expected postoperative best-corrected visual acuity of 0.2 Snellen or better
- No other secondary ocular surgeries planned during the study period
- Ability to comply with all study procedures and follow-up visits
- Ability and willingness to provide written informed consent
Exclusion Criteria:
- Preoperative ocular or systemic conditions, or medication use, that may affect study outcomes, increase risk to the participant, or predispose to complications, including infectious disease, ocular atrophy, or zonular weakness
- Poorly controlled diabetes mellitus
- Use of alpha-blockers such as tamsulosin for benign prostatic hyperplasia
- Planned femtosecond laser-assisted cataract surgery
- Congenital ocular disorders
- History of ophthalmic surgery in either eye that may affect study outcomes or increase risk, including retinal surgery, glaucoma surgery, or anterior segment surgery
- Inability to provide informed consent
- Pregnancy
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Illuminated Chopper in Right Eye
Participants assigned to this arm undergo cataract surgery using the illuminated chopper in the right eye and cataract surgery under conventional external coaxial microscope illumination in the left eye. |
Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification. Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper. |
|
Experimenteel: Illuminated Chopper in Left Eye
Participants assigned to this arm undergo cataract surgery under conventional external coaxial microscope illumination in the right eye and cataract surgery using the illuminated chopper in the left eye. |
Cataract surgery is performed using the iChopper illumination chopper with the iVision light source to provide intracameral illumination during phacoemulsification. Cataract surgery is performed under conventional external coaxial illumination from the surgical microscope without use of the illuminated chopper. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Operation Time
Tijdsspanne: During cataract surgery
|
Operation time during cataract surgery will be recorded and compared between eyes undergoing surgery with the illuminated chopper and eyes undergoing surgery with conventional microscope illumination. |
During cataract surgery
|
|
Pupil Size During Cataract Surgery
Tijdsspanne: During cataract surgery
|
Pupil size during cataract surgery will be assessed and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
|
Use of Additional Intraocular Medications
Tijdsspanne: During cataract surgery
|
The use of additional intraocular medications during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
|
Use of Additional Intraocular Devices
Tijdsspanne: During cataract surgery
|
The use of additional intraocular devices during cataract surgery will be recorded and compared between the illuminated chopper and conventional microscope illumination conditions. |
During cataract surgery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Intraoperative Complications
Tijdsspanne: During cataract surgery
|
Intraoperative complications occurring during cataract surgery, including pupil-related and other surgical complications, will be recorded and compared between the two surgical conditions. |
During cataract surgery
|
|
Postoperative Complications
Tijdsspanne: From surgery through approximately 30 days after surgery
|
Postoperative complications following cataract surgery will be recorded and compared between eyes treated with and without the illuminated chopper. |
From surgery through approximately 30 days after surgery
|
|
Postoperative Distance Visual Acuity
Tijdsspanne: Day 1 and Day 30 after surgery
|
Distance visual acuity will be assessed after cataract surgery and compared between the illuminated chopper and conventional microscope illumination conditions. |
Day 1 and Day 30 after surgery
|
|
Postoperative Intraocular Pressure
Tijdsspanne: Day 1 and Day 30 after surgery
|
Intraocular pressure will be assessed during postoperative follow-up and compared between the illuminated chopper and conventional microscope illumination conditions. |
Day 1 and Day 30 after surgery
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Incidence of Adverse Events
Tijdsspanne: From surgery through approximately 30 days after surgery
|
The incidence of adverse events following cataract surgery will be assessed, including cystoid macular edema, endophthalmitis, lens luxation, pupillary block, retinal detachment, and persistent elevation of intraocular pressure requiring treatment. |
From surgery through approximately 30 days after surgery
|
|
Incidence of Postoperative Ocular Complications
Tijdsspanne: From surgery through approximately 30 days after surgery
|
Ocular complications will be assessed, including flat anterior chamber, vitreous in the anterior chamber, residual lens material, intraocular lens decentration or tilt, posterior capsular fibrosis or opacity, and intraocular pressure elevation requiring treatment. |
From surgery through approximately 30 days after surgery
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Dong Heun Nam, MD, PhD, Gachon University Gil Medical Center, College of Medicine, Incheon, Republic of Korea
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- OCL-IIC-01
- RS-2022-00141533 (Ander subsidie-/financieringsnummer: The Korean government (the Ministry of Science and ICT; the Ministry of Trade, Industry, and Energy))
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
De-identified individual participant data may be shared with qualified researchers upon reasonable request after publication, subject to review by the study investigators and sponsor and in accordance with applicable ethical, privacy, and regulatory requirements.
IPD-tijdsbestek voor delen
Beginning after publication of the primary study results and available for 5 years thereafter.
IPD-toegangscriteria voor delen
Data will be made available to qualified researchers who submit a reasonable and scientifically sound request. Requests will be reviewed by the study investigators and sponsor. Access will be provided for approved research purposes, subject to appropriate data use agreements and compliance with applicable ethical, privacy, and regulatory requirements.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .